Table 1c. Apolipoprotein, lipoprotein, and lipase levels and synthesis and resorption markers before and 12 weeks after the drug intervention.

	Drug intervention	statin group (n = 25)	F/E group (n = 25)
apoB48 (µg/mL)	before	5.5 ± 3.7	6.1 ± 4.7
	after	5.7 ± 2.9	3.4 ± 2.8**††
apoB (mg/dL)	before	91.0 ± 16.6	98.2 ± 18.3
	after	88.9 ± 14.5	84.9 ± 18.2**
apoA1 (mg/dL)	before	148.2 ± 30.4	152.7 ± 24.1
	after	150.2 ± 28.8	164.4 ± 21.5*
Lp(a) (mg/dL)	before	14.9 ± 13.9	31.1 ± 33.7
	after	16.4 ± 13.9	24.5 ± 23.2*
LPL (ng/mL)	before	94.8 ± 37.7	87.1 ± 31.3
	after	118.6 ± 154.6	74.9 ± 26.0*
sitosterol (µg/mL)	before	3.6 ± 2.5	2.8 ± 0.8
	after	3.9 ± 3.0	0.8 ± 0.4**††
campesterol (µg/mL)	before	7.0 ± 4.1	5.8 ± 1.7
	after	7.1 ± 4.7	2.1 ± 0.5**††
lathosterol (µg/mL)	before	1.2 ± 0.8	1.7 ± 0.7
	after	1.2 ± 0.8	3.2 ± 1.9**††

F/E group, fenofibrate and ezetimibe combination group; Apo, apolipoprotein; Lp(a), lipoprotein (a); LPL, Lipoprotein lipase. Values are given as mean ± SD.

^*P < 0.05

^**P < 0.01 (vs before the drug intervention); between before and after the drug intervention comparison by paired t test or Wilcoxon test

^†P < 0.05

^††P < 0.01 (vs statin group); between statin and F/E group comparison by unpaired t test or Mann-Whitney test